NAM

Before a drug can enter clinical trials in humans, it must undergo rigorous safety evaluations to assess its potential risks. This includes identifying not only mild adverse effects, such as headaches or dizziness, but also identifying or predicting life threatening toxicities that may arise.

The Organization for Economic Co-operation and Development (OECD) and the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) both play crucial roles in harmonizing global regulations on chemicals and drugs to ensure their safe use in humans and the environment.